Adrenal minerlocorticoids pathway and its clinical applications.
Ghulam
A
A
Laboratoire de Biochimie Endocrinologique, C.H.R.U., 59037 Lille Cedex, France.
Vantyghem
M C
MC
Wemeau
J L
JL
Boersma
A
A
D000236:Adenoma / Q000097:blood / Q000378:metabolism / Q000473:pathology / Q000652:urine; D000307:Adrenal Gland Diseases / Q000378:metabolism* / Q000473:pathology; D000310:Adrenal Gland Neoplasms / Q000097:blood / Q000378:metabolism / Q000473:pathology / Q000652:urine; D000311:Adrenal Glands / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism* / Q000473:pathology; D000312:Adrenal Hyperplasia, Congenital / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D003900:Desoxycorticosterone / Q000378:metabolism; D006035:Glycyrrhiza / Q000009:adverse effects; D006801:Humans; D006929:Hyperaldosteronism / Q000378:metabolism / Q000473:pathology; D008901:Mineralocorticoids / Q000378:metabolism*; D013577:Syndrome
D008901:Mineralocorticoids; D003900:Desoxycorticosterone